• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.甲状腺激素受体保守C末端序列中的突变使激素依赖性激活与对AP-1活性的干扰相分离。
Mol Cell Biol. 1997 Aug;17(8):4687-95. doi: 10.1128/MCB.17.8.4687.
2
A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.甲状腺激素受体α与视黄酸X受体α异源二聚化诱导的配体反应性转变。
Mol Cell Biol. 1996 Jan;16(1):219-27. doi: 10.1128/MCB.16.1.219.
3
Role of the conserved C-terminal region of thyroid hormone receptor-alpha in ligand-dependent transcriptional activation.甲状腺激素受体α保守C末端区域在配体依赖性转录激活中的作用。
Mol Cell Endocrinol. 1998 Mar 16;138(1-2):105-14. doi: 10.1016/s0303-7207(98)00016-1.
4
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).在v-ErbA中缺失的保守C末端序列对c-ErbA(甲状腺激素受体)的生物学活性至关重要。
Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993.
5
A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.甲状腺激素受体α的N端A/B结构域中的一个10氨基酸序列对于转录激活以及与通用转录因子TFIIB的相互作用至关重要。
Mol Cell Biol. 1995 Aug;15(8):4507-17. doi: 10.1128/MCB.15.8.4507.
6
GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.GRIP1,一种类固醇、甲状腺、视黄酸和维生素D受体的AF-2反式激活结构域的转录共激活因子。
Mol Cell Biol. 1997 May;17(5):2735-44. doi: 10.1128/MCB.17.5.2735.
7
Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.甲状腺激素受体对基因表达的组成性激活是由p53介导的抑制作用的逆转所导致的。
Mol Cell Biol. 1997 Dec;17(12):7195-207. doi: 10.1128/MCB.17.12.7195.
8
Hormone-dependent and -independent transcriptional activation by thyroid hormone receptors are mediated by different mechanisms.甲状腺激素受体介导的激素依赖性和非依赖性转录激活是由不同机制介导的。
Endocrinology. 1996 Feb;137(2):390-9. doi: 10.1210/endo.137.2.8593781.
9
Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.甲状腺激素和视黄酸受体与一种抑制性细胞因子的配体依赖性解离的功能证据。
Mol Cell Biol. 1994 Sep;14(9):5756-65. doi: 10.1128/mcb.14.9.5756-5765.1994.
10
Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.雄激素受体AF-2(激活功能2)核心结构域的突变分析揭示了与其他核受体相比保守残基的功能和机制差异。
Mol Endocrinol. 2000 Oct;14(10):1603-17. doi: 10.1210/mend.14.10.0544.

引用本文的文献

1
Patterns of gene expression in the sheep heart during the perinatal period revealed by transcriptomic modeling.转录组学建模揭示围产期绵羊心脏中的基因表达模式。
Physiol Genomics. 2015 Sep;47(9):407-19. doi: 10.1152/physiolgenomics.00027.2015. Epub 2015 Jun 30.
2
General molecular biology and architecture of nuclear receptors.核受体的一般分子生物学和结构。
Curr Top Med Chem. 2012;12(6):486-504. doi: 10.2174/156802612799436641.
3
Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles.打破循环:深入了解雌激素受体α在真核细胞周期中的作用。
J Carcinog. 2011;10:25. doi: 10.4103/1477-3163.90440. Epub 2011 Nov 30.
4
Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.转录因子 AP1 增强染色质可及性和糖皮质激素受体结合。
Mol Cell. 2011 Jul 8;43(1):145-55. doi: 10.1016/j.molcel.2011.06.016.
5
Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling.Jak2蛋白在丝氨酸523位点的磷酸化抑制Jak2依赖的瘦素受体信号传导。
Mol Cell Biol. 2006 Jun;26(11):4063-73. doi: 10.1128/MCB.01589-05.
6
Multiple mutations contribute to repression by the v-Erb A oncoprotein.多种突变导致v-Erb A癌蛋白发挥抑制作用。
Oncogene. 2005 Oct 13;24(45):6737-52. doi: 10.1038/sj.onc.1208826.
7
The thyroid hormone receptor antagonizes CREB-mediated transcription.甲状腺激素受体拮抗CREB介导的转录。
EMBO J. 2003 Jun 16;22(12):3102-12. doi: 10.1093/emboj/cdg295.
8
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.在介导佛波酯和激素调控的胶原酶-3反应元件处的因子募集及TIF2/GRIP1共抑制因子活性。
EMBO J. 2001 Nov 1;20(21):6071-83. doi: 10.1093/emboj/20.21.6071.
9
CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.CIA,一种具有双功能核受体相互作用决定簇的新型雌激素受体共激活因子。
Mol Cell Biol. 2001 Jan;21(1):343-53. doi: 10.1128/MCB.21.1.343-353.2001.
10
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.雌二醇对肿瘤坏死因子-α转录的抑制作用需要雌激素受体激活功能-2,并且共激活因子可增强这种抑制作用。
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15161-6. doi: 10.1073/pnas.96.26.15161.

本文引用的文献

1
Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors.鉴定TRACs(T3受体相关辅因子),这是一类与核激素受体结合并调节其活性的辅因子家族。
Mol Endocrinol. 1996 Jul;10(7):813-25. doi: 10.1210/mend.10.7.8813722.
2
GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors.GRIP1,一种新型小鼠蛋白,在酵母中作为类固醇受体激素结合域的转录共激活因子。
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4948-52. doi: 10.1073/pnas.93.10.4948.
3
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.一种CBP整合蛋白复合体介导核受体的转录激活和AP-1抑制作用。
Cell. 1996 May 3;85(3):403-14. doi: 10.1016/s0092-8674(00)81118-6.
4
A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.甲状腺激素受体α与视黄酸X受体α异源二聚化诱导的配体反应性转变。
Mol Cell Biol. 1996 Jan;16(1):219-27. doi: 10.1128/MCB.16.1.219.
5
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).在v-ErbA中缺失的保守C末端序列对c-ErbA(甲状腺激素受体)的生物学活性至关重要。
Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993.
6
A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.糖皮质激素受体单体中存在一个独特的调节结构域,可抑制转录因子AP-1的活性。
EMBO J. 1994 Sep 1;13(17):4087-95. doi: 10.1002/j.1460-2075.1994.tb06726.x.
7
c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.由不同于JNK和ERK的H-Ras激活蛋白激酶刺激的c-Fos转录活性。
Nature. 1994 Sep 8;371(6493):171-5. doi: 10.1038/371171a0.
8
Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor.甲状腺激素受体配体依赖性反式激活结构域的特性分析
EMBO J. 1994 Jul 1;13(13):3039-49. doi: 10.1002/j.1460-2075.1994.tb06603.x.
9
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.环磷酸腺苷(cAMP)和有丝分裂原反应基因的激活依赖于一种共同的核因子。
Nature. 1994 Jul 21;370(6486):226-9. doi: 10.1038/370226a0.
10
Functional analysis of a transactivation domain in the thyroid hormone beta receptor.甲状腺激素β受体中转录激活结构域的功能分析
J Biol Chem. 1994 Dec 9;269(49):31157-61.

甲状腺激素受体保守C末端序列中的突变使激素依赖性激活与对AP-1活性的干扰相分离。

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

作者信息

Saatcioglu F, Lopez G, West B L, Zandi E, Feng W, Lu H, Esmaili A, Apriletti J W, Kushner P J, Baxter J D, Karin M

机构信息

Department of Pharmacology, Center for Molecular Genetics, School of Medicine, University of California at San Diego, La Jolla 92093-0636, USA.

出版信息

Mol Cell Biol. 1997 Aug;17(8):4687-95. doi: 10.1128/MCB.17.8.4687.

DOI:10.1128/MCB.17.8.4687
PMID:9234725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC232321/
Abstract

A short C-terminal sequence that is deleted in the v-ErbA oncoprotein and conserved in members of the nuclear receptor superfamily is required for normal biological function of its normal cellular counterpart, the thyroid hormone receptor alpha (T3R alpha). We carried out an extensive mutational analysis of this region based on the crystal structure of the hormone-bound ligand binding domain of T3R alpha. Mutagenesis of Leu398 or Glu401, which are surface exposed according to the crystal structure, completely blocks or significantly impairs T3-dependent transcriptional activation but does not affect or only partially diminishes interference with AP-1 activity. These are the first mutations that clearly dissociate these activities for T3R alpha. Substitution of Leu400, which is also surface exposed, does not affect interference with AP-1 activity and only partially diminishes T3-dependent transactivation. None of the mutations affect ligand-independent transactivation, consistent with previous findings that this activity is mediated by the N-terminal domain of T3R alpha. The loss of ligand-dependent transactivation for some mutants can largely be reversed in the presence of GRIP1, which acts as a strong ligand-dependent coactivator for wild-type T3R alpha. There is excellent correlation between T3-dependent in vitro association of GRIP1 with T3R alpha mutants and their ability to support T3-dependent transcriptional activation. Therefore, GRIP1, previously found to interact with the glucocorticoid, estrogen, and androgen receptors, may also have a role in T3R alpha-mediated ligand-dependent transcriptional activation. When fused to a heterologous DNA binding domain, that of the yeast transactivator GAL4, the conserved C terminus of T3R alpha functions as a strong ligand-independent activator in both mammalian and yeast cells. However, point mutations within this region have drastically different effects on these activities compared to their effect on the full-length T3R alpha. We conclude that the C-terminal conserved region contains a recognition surface for GRIP1 or a similar coactivator that facilitates its interaction with the basal transcriptional apparatus. While important for ligand-dependent transactivation, this interaction surface is not directly involved in transrepression of AP-1 activity.

摘要

v-ErbA癌蛋白中缺失但在核受体超家族成员中保守的短C末端序列,是其正常细胞对应物甲状腺激素受体α(T3Rα)正常生物学功能所必需的。我们基于T3Rα激素结合配体结合域的晶体结构对该区域进行了广泛的突变分析。根据晶体结构,表面暴露的Leu398或Glu401的诱变完全阻断或显著损害T3依赖的转录激活,但不影响或仅部分减少对AP-1活性的干扰。这些是首次能明确区分T3Rα这些活性的突变。同样表面暴露的Leu400的替代不影响对AP-1活性的干扰,仅部分减少T3依赖的反式激活。这些突变均不影响非配体依赖的反式激活,这与之前该活性由T3Rα的N末端结构域介导的发现一致。在存在GRIP1的情况下,一些突变体的配体依赖反式激活的丧失在很大程度上可以逆转,GRIP1对野生型T3Rα起强大的配体依赖共激活剂作用。GRIP1与T3Rα突变体的T3依赖体外结合与其支持T3依赖转录激活的能力之间存在极好的相关性。因此,之前发现与糖皮质激素、雌激素和雄激素受体相互作用的GRIP1,可能在T3Rα介导的配体依赖转录激活中也起作用。当与酵母反式激活因子GAL4的异源DNA结合结构域融合时,T3Rα保守的C末端在哺乳动物和酵母细胞中均作为强大的非配体依赖激活剂发挥作用。然而,与它们对全长T3Rα的影响相比,该区域内的点突变对这些活性有截然不同的影响。我们得出结论,C末端保守区域包含一个GRIP1或类似共激活剂的识别表面,这促进了它与基础转录装置的相互作用。虽然对配体依赖的反式激活很重要,但这种相互作用表面并不直接参与AP-1活性的反式抑制。